Inventory increased 60.9%
Inventory changed +60.9% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory changed +60.9% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating margin changed -7796 basis points from the comparable as-filed period.
Cash & equivalents changed +33.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Research & development changed +253.7% from the comparable as-filed period.
Working capital changed +38.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Current assets changed +29.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Shares outstanding changed +3.8% from the comparable as-filed period. The change ranks at the 88th percentile of 8 prior comparable changes.
Revenue changed +14.0% from the comparable as-filed period.
Operating income changed -259.7% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Inventory / revenue changed +251 basis points from the comparable as-filed period.
Operating cash flow changed -220.7% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Working capital / assets changed +961 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Total assets changed +15.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Operating cash-flow margin changed -8432 basis points from the comparable as-filed period.
R&D / revenue changed +7797 basis points from the comparable as-filed period.
Gross margin changed +26 basis points from the comparable as-filed period.
Current ratio changed +20.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Selling, general & administrative changed +10.7% from the comparable as-filed period.
Current liabilities changed +7.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Cost of revenue changed +9.8% from the comparable as-filed period.
Stock-based compensation changed +13.3% from the comparable as-filed period.
SBC / revenue changed -3 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.